Package leaflet: Information for the user. Carmellose sodium

Similar documents
Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the patient

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PATIENT INFORMATION LEAFLET

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user

Package leaflet: Information for the user

Package Leaflet: Information for the user

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

1. What Faslodex is and what it is used for

Package leaflet: Information for the patient

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

PATIENT INFORMATION LEAFLET. Urea 10% w/w Cream

TYPHIM Vi, Solution for injection

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package leaflet: Information for the patient

Package leaflet: Information for the user

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Atrosan Devil s Claw film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package Leaflet: Information for the user. Digestisan oral drops

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

ZADITEN Eye Drops 1.0%

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the user. COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

Package leaflet: Information for the user

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

1. What Ursofalk 250mg hard capsules are and what they are used for

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Gyno-Pevaryl Once 150mg vaginal pessary

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package Leaflet: Information for the User

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the user. Tremfya 100 mg solution for injection in pre-filled syringe guselkumab

1 What Flixonase is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Transcription:

Package leaflet: Information for the user CELLUVISC 0.5% w/v, eye drops, solution, unit dose Carmellose sodium Read all of this leaflet carefully before you start using this medicine because it contains important information for you. This medicine is available without prescription from pharmacies. Always use this medicine exactly as described in this leaflet or as your pharmacist or nurse has told you. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if you feel worse. What is in this leaflet 1. What CELLUVISC is and what it is used for 2. What you need to know before you use CELLUVISC 3. How to use CELLUVISC 4. Possible side effects 5. How to store CELLUVISC 6. Contents of the pack and other information 1. What CELLUVISC is and what it is used for CELLUVISC is a substitute for tears, and contains the lubricant called carmellose sodium. It is used for the treatment of the symptoms of dry eye (such as soreness, burning, irritation or dryness) caused by you not producing enough tears to keep the eye wet. 2. What you need to know before you use CELLUVISC Do not use CELLUVISC If you are hypersensitive (allergic) to carmellose sodium or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions If irritation, pain, redness or changes in vision occur or if you feel your condition is getting worse, stop taking this medicine and consult your doctor or pharmacist. Other medicines and CELLUVISC Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription. If you are using other eye drops, leave at least 15 minutes between putting in the other drops and CELLUVISC.

Pregnancy and breast-feeding You can use CELLUVISC if you are pregnant and when you are breast-feeding. Driving and using machines CELLUVISC may cause temporary blurring of vision. If you do experience temporary blurring, do not drive or use machines until your sight is clear. Read all the information in this leaflet before using CELLUVISC. If you are unsure about anything, discuss it with your doctor, nurse or pharmacist. 3. How to use CELLUVISC Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. The recommended dose is 1-2 drops of CELLUVISC in the affected eye/each affected eye, 4 times a day or as often as needed. You do not need to remove contact lenses before using CELLUVISC. Make sure that the single-dose container is intact before use. The solution should be used immediately after opening. To avoid contamination or possible eye injury, do not let the open-end of the single-dose container touch your eye or anything else. Wash your hands before use. 1. Tear one single-dose container from the strip. 2. Hold the single-dose container upright (with the top uppermost) and twist off the top. 3. Gently pull down the lower eyelid to form a pocket. Turn the single-dose container upside down and squeeze it to release one drop into each eye. Blink your eyes a few times. Do not re-use the single-dose container even if there is some solution left. It is most important that you throw it away and do not keep it. If you use more CELLUVISC than you should It will not cause you any harm. If you are worried, talk to your doctor or pharmacist.

If you forget to use CELLUVISC Use a single drop in each eye that needs treatment as soon as you remember, and then go back to your regular routine. Do not use a large number of drops to make up for forgetting to put drops in your eye or eyes earlier. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects are classified into the following categories, depending on how often they occur: Very common Common Uncommon Rare Very rare Not known may affect more than 1 in 10 people may affect up to 1 in 10 people may affect up to 1 in 100 people may affect up to 1 in 1,000 people may affect up to 1 in 10,000 people frequency cannot be estimated from the available data The following side effects may be seen with CELLUVISC : Common Not known Eye irritation (including burning and discomfort), eye pain, itchy eyes, visual disturbance. Allergic reactions (including eye allergy), blurred vision, sticky eye, watery eye, redness of the eye, eye injury to the surface of the eye due to the tip of the vial touching the eye during use. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via: UK Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie

By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store CELLUVISC Keep this medicine out of the sight and reach of children. Do not store above 25 C. Do not use this medicine after the expiry date (use by date) which is stated on the single-dose container tab and the carton after EXP:. The expiry date refers to the last day of that month. Do not use if CELLUVISC packaging shows evidence of tampering. Do not use if solution changes colour or becomes cloudy. Used CELLUVISC eye drop containers can be disposed of as household waste. Any unused containers can be returned to the pharmacist or he can tell you how to dispose of them safely (in order to protect the environment). 6. Contents of the pack and other information What CELLUVISC contains The active ingredient is carmellose sodium 5 mg/ml. The other ingredients are sodium chloride, sodium lactate, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate and purified water. Small amounts of sodium hydroxide or hydrochloric acid may be added to bring the solution to the correct ph (a measure of the acidity or alkalinity of the solution). The ingredients and the amount used in CELLUVISC were chosen to match what appears in tears produced naturally by the eye. What CELLUVISC looks like and contents of the pack CELLUVISC is a clear, colourless to pale yellow eye drops solution in a small seethrough (bubble-like) casing (known as a single-dose container ). The single-dose container has a twist-off top. Each single-dose container contains 0.4 ml of eye drops solution. Each pack contains 5, 30 or 90 single-dose containers. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Allergan Pharmaceuticals Ireland Castlebar Road Westport County Mayo Ireland

For any further information about this medicine product, please contact the local representative of the Marketing Authorisation Holder: Allergan Limited 1st Floor Marlow International The Parkway, Marlow Buckinghamshire SL7 1YL United Kingdom Tel. 01628 494026 E-mail: uk_medinfo@allergan.com This leaflet was last revised in 11/2014. Version 3.